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1  Introduction and aim of the project 
The importance of investigations on drug related compounds are on a notable rise during the 
recent years. These compounds may be considered in various fields, including early stage 
drug development, metabolism studies and environmental analyses.  
One route for generation of such compounds is the interaction of photoirradiation with drug 
substances, which may lead to decreasing effective concentration of the drug substance and 
formation of photoproducts. The generated photoproducts may be associated with biological 
adverse effects as well as ecotoxicological aspects. Thus, pharmaceutical companies are 
requested by regulatory agencies to provide data on drug photochemical properties and 
sequential potential toxicological effects, which are demanding tasks, requiring animal testing 
and being time and cost consuming. 
In this work, investigations on the photochemical stability of pharmaceutical substances as well 
as mass spectral characterization of drug related compounds will be discussed using 
ketoprofen and its related benzophenone impurities including those listed in the European 
Pharmacopeia (Ph. Eur. 9.0) as model compounds.  
The goal of this project is to establish a modernized method for easy and fast photostability 
testing using an online reactor LC hyphenation and to develop a complementary approach that 
comprises recent mass spectrometric techniques and isotopic labelling for structural 
elucidation of drug related compounds.  
The established photostability assay and accompanying mass spectrometric approach provide 
the ability to perform kinetic studies, detect the photoproducts of the active pharmaceutical 
ingredient (API) in vitro and assist the photosensitivity tests of API in vivo . To narrow the gap 
between drug photodegradation and formed compounds including intermediate products, fast 
identification has to be realized with the capability to isolate resulting substances in order to 
offer them as reference standards for further confirmation and phototoxicity tests.  
Structural elucidation of drug related compounds including those previously formed in the 
context of the work and defined as photoproducts should be feasible by establishing an 
universal approach based on recent mass spectrometric instrumentation, isotopic labelling and 
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2 Theoretical Background 
 
2.1 Photostability of drug substances 
Photosynthesis in plants and vitamin D production in mammals demonstrate the essential role 
of sunlight for life on Earth. Nevertheless, sunlight may also lead to skin aging, cancer and 
photoderamtoses [1]. Related to this, photosensitivity is reported to make (8%) of unwanted 
side effects of drugs [2]. 
Thus, photochemical properties of drug substances and their associated phototoxicity received 
increasing attention and are reflected in many recently published studies [3-13]. The European 
Pharmacopeia lists more than 250 substances as photolabile [14]. Upon photodecomposition, 
the effective concentration of the API can be decreased and photoproducts may be generated 
which can lead to considerable amounts of adverse effects when administered. Furthermore, 
phototoxic products may also be generated in the body at the irradiation after drug 
administration [15, 16]. These resulting photoproducts may have an influence on the 
macromolecules that make up the normal cell and can lead to DNA damage, lipid peroxidation 
as well as reaction with proteins. As a final consequence cell damage may occur [17, 18].  
Moreover, long irradiation of pharmaceuticals and their metabolites in surface water or during 
wastewater treatment results in worldwide problems with environment pollution [19, 20]. The 
transformation products may then be more toxic than their precursor compound [21, 22]. These 
problems have increased the concern about ecotoxicological aspects of photodegradation of 
drug substances. 
Therefore, knowledge about photochemical properties of API is a core stone in the drug life 
cycle from the early stage of drug development, through the drug supply chain, including 
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2.1.1 The photochemical process and photosensitizing reactions 
 
The photochemical process relies on the absorption spectrum of the drug molecule as can be 
deduced from the basic law of photochemical absorption by Grotthus and Draper which states 
that no photochemical (or subsequent photobiological) reaction can occur unless 
electromagnetic radiation is absorbed [14]. Due to retention of shorter wavelengths by the 
ozone layer direct photodegradation via sunlight can occur only, if the substance absorbs 
radiation λ > 290 nm. However, degradation of photolabile compounds besides this limitation 
is also possible if artificial light sources such as low pressure mercury lamps are used.   
The energy-level diagram in figure 3 outlines the photochemical process. After absorption of 
electromagnetic radiation the process starts with excitation of a drug molecule from its ground 
state (D0) to the excited state (1D) in which a valence electron moves to the first available outer 
shell corresponding to the first singlet state. 
 
 
Figure 3 Energy levels of molecules showing transitions after irradiation absorption based on 
Tonnesen [14]: 1. vibrational relaxation; 2. internal conversion; 3. intersystem crossing; 4. thermal 
activation 
 
As the excited state (1D) is less stable than the ground state (D0), usually rapid deactivation 
occurs. This deactivation comprises different competing physical processes and can be 
achieved via internal conversion (IC), which is a non-radiative transition between states of like 
multiplicity, or by photon emission (fluorescence). Photoionization (removal of an electron from 
a molecule) as well as vibrational relaxation may also be included. 
The odds of an excited singlet state molecule interacting with neighbouring molecules is limited 
as the lifetime of the mentioned state is generally restricted in nanoseconds. However, 
intersystem crossing (ISC) may occur from the excited singlet state to an excited triplet state 
Ground state (D0) Excited singlet state (
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(electron spin parallel). Due to its relatively longer lifetime the triplet state of the molecule has 
much higher likelihood to interact with other molecules. Furthermore, the excited molecule has 
the ability to form a complex with other species including the ground state of the drug molecule 
itself. Depending on the ability of the excited state to donate or accept electrons from ground 
state molecules, an electron transfer leading to a chemical reaction may occur as oxidative or 
reductive reaction. A pair of radical ions can be then produced that is able to react further with 
oxygen. As a final consequence superoxide anions can be formed. If the drug molecule is an 
olefin, for example, a dioxetane can be formed which further dissociates to yield ketones. 
Generally, a transfer of reactivity to a species other than that absorbing the radiation (D0) is 
known as photosensitization reaction, which follow one of two different reaction pathways: The 
first type reactions or free radical reactions (type 1) involve electron transfer, including 
simultaneous transfer of a proton corresponding to the transfer of a hydrogen atom (Equation 1 
to Equation 3), whereas type 2 reactions include formation of excited singlet oxygen by energy 
transfer with spin conservation (Equation 5). These processes have a competitive fashion and 
their distribution depends on sensitizer, solvent, substrate, oxygen concentration, and affinity 
of sensitizer and substrate.  
 
Free radical formation                              3D + AH              D0 + A● + H+                                       1 
Or                                                           3D + AH             DH + A●                                            2 
Or                                                            3D + AH              D0 + A
─ + H+                                   3 
(Type 1 photo-oxidation)                          A● (A● ─) + O2             AO2●  (or AO2●─)                      4  
Energy Transfer to oxygen:                     3D +  3O2               D0 +  1O2                                           5 
Oxidation by singlet oxygen                     1O2 +  AH               AOOH                                              6 
(type 2 photo-oxidation) 
 
The radicals formed from the type 1 mechanism may undergo further reactions. While these 
reactions in absence of oxygen (non-photodynamic reactions) means recombination, 
dimerization or disproportionation, molecular oxygen (when it is available in sufficient 
concentration) is rapidly added to the radical (photodynamic reactions). The formed peroxy 
radical will then stabilize itself by proton abstraction from neighboring molecules. This 
mechanism of interaction can be performed as chain reaction, which has the most damaging 
potential on biological systems [23]. 
In addition to the free radicals or singlet oxygen formation in type 1 and type 2 reactions, 
several short-lived species such as hydroxy radicals and superoxide radicals are generated 
whom together with singlet oxygen are termed reactive oxygen species and play a critical role 
in photosensitization reactions.  




Sunlight specially its UV component can induce or exacerbate a wide variety of skin disorders 
known as photodermatoses [24, 25]. They may be divided into primary and secondary types 
as illustrated in figure 4. Primary photodermatoses are induced by photosensitizing substances 
and for their occurrence electromagnetic radiation is considered as critical pathogenic factor, 
whereas secondary photodermatoses have another genesis in addition to sunlight induction 
(altogether) and they are expressed as systemic diseases, metabolic disorders, or disorders 
of DNA repair [26].  
Primary photodermatoses can be further subdivided into primary idiopathic photodermatoses, 
which occur with unknown etiology, and photosensitivity reactions associated with known 
photosensitizers. Comparably, Photosensitivity reactions with known photosensitizers can be 
further divided into photoallergic and phototoxic reactions (figure 4). 
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2.1.3 Photosensitivity induced by drug substances 
 
A photosensitive reaction induced by chemicals is illustrated in figure 5. It is defined as 
development of cutaneous disease due to the interaction of a given chemical agent 
(photosensitizer) with sunlight [27]. This photosensitivity type can be divided in several 
categories:  
• Phototoxic reaction: an acute toxic response that occurs after exposure of the skin to 
new chemical entities and subsequent exposure to light/UV radiation. It can also be 
induced by skin irradiation after systemic administration of a chemical. When the 
phototoxic reactions are induced by chemicals within 0–72 hours after exposure to 
light/UV radiation they are generally named as photoirritation [28].  
• In contrast to phototoxic reactions, photoallergy is an acquired immunological reactivity, 
which requires multiple exposures of photosensitizer and light /UV radiation. An 
induction period of one or two weeks is required before skin reactivity can be 
demonstrated [28].  
• Photogenotoxicity is a genotoxic response, which is observed after exposure to a 
chemical (a photosensitizer) and a (non)-genotoxic dose of light/UV resulting in 
formation of genotoxic species. 
• Photocarcinogenicity represents a possible transformation, caused by visible or UV 
radiation of a compound resulting in formation of carcinogenic species.  
Among photosensitivity reactions, phototoxicity is reported to be the most common adverse 
effect and can appear in any patient after enough irradiation doses and sufficient concentration 
of the photosensitizer. The clinical manifestations of phototoxicity are similar to sunburn and 
include erythema, edema and severe pigmentation.  
In contrast to phototoxicity, photoallergy is relatively uncommon as it occurs provided that a 
specific sensitization has been acquired. However, photoallergy requires lower doses of both 
photosensitizer and radiation energy than phototoxicity. The acute clinical expressions are 
restricted to light exposed area of the skin and there are signs of allergic contact dermatitis 
with erythemas, papular vesicles, and rarely blisters [26].  
Two major pathways can be considered by which photosensitizing drugs may produce a 
phototoxic skin response involving either the excited triplet state or free radical entities. Most 
of the macromolecules that make up the normal cell are susceptible to oxidative degradation 
of the type occurring in photodynamic reactions. Lipids in the cell membranes can react at their 
unsaturated sites through both free radical (type 1) and singlet oxygen (type 2) mediated 
processes. As final consequences, these result in splitting of the lipid molecule into shorter 
fatty acids and a disruption of the cellular membrane. Proteins are oxidized specially via their 
amino acid side chains. The two most susceptible amino acids are histidine and tryptophan 
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The imidazole group of histidine is a specific substrate for singlet oxygen (type 2) while the 
indole group of tryptophan experiences both type 1 and type 2 reactions. 
UVA is able to penetrate further and has the potential to cause photoreactions deeper in the 
skin than shortwave limit of sunlight (UVB), which can only reach the viable layers of the 
epidermis [29]. In spite of its relatively weak absorption by proteins and nucleic acids, 
epidemiological studies suggest UVA to play an important role in skin cancers. This is caused 
via photosensitisers such as pharmaceuticals which absorb photons and generate excited 
molecules [30]. Those molecules are then able to react with DNA and proteins either through 
an electron transfer (type 1 mechanism) or by reaction between DNA and singlet-oxygen to 
form 8-oxoguanine (type 2 mechanism). Type 2 mechanism may also be initiated through 
formation of a superoxide anion radical which undergoes disproportionation reaction, yielding 
hydrogen peroxide and reactive oxygen species. 
Drugs, which are reported frequently to give rise to some form of photosensitivity responses 
show a wide range of pharmacological activities and different chemical structures. The list of 
these drugs includes sulfonamides, tetracyclines, quinolones, sulfonylureas, thiazides, 
phenothiazines, furocoumarins and nonsteroidal anti-inflammatory drugs (NSAIDs). 
Photosensitizing chemicals usually have a low molecular weight (200 to 500 Daltons) and a 
planar, tricyclic, or polycyclic configuration, often with heteroatoms in their structures enabling 
resonance stabilisation. All of them absorb ultraviolet and/or visible radiation, regarded as an 
essential characteristic for a chemical to be considered as a photosensitizer. 
Photodegradation and free radical formation have on the other hand numerous advantages. 
Besides the beneficial conversion of 7-dehydrocholesterol to vitamin D3 in skin via UV 
radiation, PUVA therapy, a combination of psoralens and UVA light, is well established in the 
treatment of psoriasis. Light-activated liposomes or prodrugs may also be used as new drug 
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2.1.4 Ecotoxicological aspects of drug photodegradation 
 
Pharmaceuticals as well as other chemicals can reach the environment by various routes such 
as excretion, wastewater effluents, industrial waste from manufacturing, or agriculture [32, 33]. 
Many drug substances have been detected in natural water including lakes and rivers, high 
concentrations of some of these drugs have been frequently identified in influent and effluent 
of urban wastewater as well as in hospital effluents [34, 35]. Moreover, after drug 
administration the formed metabolites are excreted and should be considered as 
environmental pollutants. Conventional wastewater treatment which consists of two parts, 
physio-chemical (primary treatment) and biological (secondary treatment), is not often effective 
enough to remove these pharmaceuticals [36].  
Here, positive and negative environmental aspects can be seen regarding the interaction of 
drug substances with visible and UV radiation. Environmental pollution problems caused by 
the emission of certain pharmaceuticals and their metabolites into the water environment were 
recognized [37-39]. The resulting transformation products may pose then greater risks than 
their parent compounds [40].  
These problems have increased the concern about ecotoxicological effects on aquatic 
organisms and potential for the appearance of drug-resistant bacteria or viruses in the water 
environment [41-45]. Many pharmaceuticals were previously known to undergo direct sunlight 
photolysis and transformation in surface waters; however, the synergistic increase in toxicity 
caused by photo-by-products cannot be ignored. The sunlight can also alter dissolved organic 
matter (DOM) either directly leading to free radical formation or indirectly via residues of 
photosensitizes including pharmaceuticals [46]. 
Residues of azole fungicides, for example, can undergo photolysis under UV irradiation in 
wastewater. Thereby, products may cause toxic effects on aquatic organisms such as algae 
and fish [47-49]. Ibuprofen, in its turn, was found to cause histopathological changes 
(microscopic anatomical changes in diseased tissue) in the gills and kidneys of fish after long 
UV exposure [50]. However, modern wastewater treatment methods among others include 
advanced oxidation processes (AOPs) which are based on formation of active oxygen species 
(AOS). AOPs can be performed with or without radiation. Solar radiation itself may be applied 
during such treatment processes with pharmaceuticals absorbing irradiation over 290 nm. 
Furthermore direct photodegradation using UVC-radiation of other compounds can be 
performed and was reported by several publications [51-53]. Some wastewater treatment 
methods realized the use of a combination of UV radiation and hydrogen peroxide (H2O2). In 
this case hydroxy radicals are produced, which substantially increase the degradation rate of 
targeted compounds in comparison to UV alone, thereby enhancing the removal of lots of 
pharmaceuticals although some of them can resist such a treatment [54]. Another example of 
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irradiation usage in modern wastewater treatment is the combination of Fenton process (Eq. 7 
and 10) with UV, which regenerates Fe2+ from the formed aqua-complexes during the Fenton 
process (Eq. 9). Furthermore, the yield of hydroxy radicals is increased through direct H2O2 
irradiation (Eq. 10) [55].  
 
 
Fe2+ + H2O2              Fe3+  + OH─HO●                                          7 
Fe3+ + H2O2              Fe2+ + HO2● + H+                                       8 
[(Fe (H2O)5(OH)]2+ + h              Fe+2 + H+ + HO●                      9 
H2O2     +   h              2HO●                                                     10 
 
As mentioned previously, elimination of drug molecules via photoirradiation may result in 
compounds that can be more toxic than origin compounds. Therefore, further investigation on 
the resulting photoproducts via sunlight or after some modern waste water treatments should 
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2.1.5 Analytical photodegradation studies of drug substances 
 
The application of the ICH Harmonized Tripartite Guideline on Photostability Testing of New 
Drug Substances and Products (ICH Q1B) started in Europe in 1996 and in the US and Japan 
in 1997. Investigations on photochemical stability of pharmaceutical substances are required 
for new drug licensing since 1998 in the US, the European Union, Japan, and Canada [56]. 
The (ICH Q1B) guideline divides the photostability tests in forced degradation testing and 
confirmatory testing. According to the guideline, confirmatory studies should provide the 
information necessary for handling, packaging, and labelling. For confirmatory testing the 
overall illumination of the sample is defined to be not less than 1.2 million lux hours and 
integrated near ultraviolet energy should not be less than 200 watt Wh/m 2. 
The purpose of forced degradation testing studies is to evaluate the overall photosensitivity of 
the material for method development purposes and/or photodegradation pathway elucidation. 
The design of forced degradation experiments on drug substances is left to the applicant’s 
discretion.  
It should be noted that many drug substances are exposed to light for long durations such as 
infusion solutions which are often stored in transparent bottles. This issue may not be perfectly 
covered by Q1B guideline. The guideline may also not cover all steps in the drug supply chain, 
for example dilution and reconstitution before administration. Therefore, a second exposure 
time for confirmatory studies with 6 million lux hours instead of 1.2 million lux hours was 
proposed by Baertschi et al. [57].  
In order to detect the photoproducts long exposure periods in photostability chambers and 
several preparative steps during the entire study are usually required. This may affect the 
whole result especially the identification of the photoproducts and intermediate products as 
well as the investigation of the chemical background of the initiated phototoxic compounds. 
Furthermore, Q1B guideline covers neither photoproducts generated in vivo under sunlight 
exposure of the skin nor those generated in surface water. 
For the separation of resulting products, chromatographic methods are commonly used in the 
context of photodegradation of pharmaceuticals. High performance liquid chromatography 
(HPLC) is often the method of choice, whereas gas chromatography (GC) may also be used 
after transformation into volatile status for limited volatile substances. 
During such studies, a variety of detectors is implemented after appropriate separation 
techniques. Conventional UV/VIS detection shows its limitation regarding structure elucidation 
of the resulting photoproducts and is therefore, suitable for quantitative analysis or for 
identification by retention time only. Ultra-high-performance liquid chromatography coupled 
with diode array detector (DAD) can improve the detection and shorten the time required for 
separation on photodegradation studies than HPLC-DAD and enable measuring of a wide 
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variety of absorbing substances present in the samples. Mass spectrometry (MS) 
demonstrates its potential as a powerful tool for photoproduct detection as well as structural 
elucidation. NMR and IR are also recommended. However, they are both much less sensitive 
than MS. In case of MS techniques, matrix effect problems should be considered especially 
with environmental samples and electron spray ionization sources. Such obstacles may be 
overcome by appropriate sample preparation [58, 59]. According to a recent study by Trawiński 
and Skibiński on photodegradation of psychotropic drugs, chromatographic and mass 
spectrometric methods are the most often applied (figure 6) [22]. For faster separation and 
sequential detection, photochemical derivatization can be applied as the simplest 
derivatization method in liquid chromatography. However, it is used least often and generally 
unfamiliar to analytical chemists. This can attribute to the operating problems emerged in the 
early years, which limit the routine use of such instrumentation, including among others leaking 
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2.2 The role of mass spectrometry in the identification of unknown 
drug related compounds 
Mass spectrometry plays an important role as one of the most edifying techniques used to 
identify pharmaceutical substances and enhance the detection of both process and 
degradation-related compounds [62-65]. In contrast to the active pharmaceutical ingredient 
(API), impurities and transformation products provide no benefits to the patients and convey 
only risks [65-67]. Hyphenation with appropriate chromatographic separation technologies and 
the recent development in software and instrumentation have improved the potential of MS for 
structural characterization of unknow analytes. However, confidence in these MS-
identifications varies between studies and substances, since it is not always possible or even 
meaningful to synthesize each substance or confirm them via other methods (e.g., nuclear 
magnetic resonance) [68]. In order to reduce time consumed in identification of unknown 
substances, fragment ions and isotopic labelling accompanied with different derivatization 
methods may help to further substantiate structural proposals. Thus, assessing MS and 
MS/MS spectra libraries and associated interpretation of the emerged fragment ions for drug 
molecules and their related compounds are of core importance. 
Through this work, a universal approach is introduced to identify the fragment ions of 
ketoprofen and its related benzophenone derivatives as model compounds including those 


















Theoretical Background 16 
 
2.2.1 The utilized mass spectrometric techniques 
 
Single quadrupole mass spectrometry (Q) and Quadrupole-Time-of-Flight mass spectrometry 
(QTOF-MS) were used for the identification of the analytes. Single quadrupole provides 
several advantages including its relatively low cost and small size. However, it demonstrates 
limited capability in terms of mass range and resolving power [69]. Further inspection on the 
analytes was achieved by utilizing QTOF-MS which is composed of a quadrupole mass filter 
(Q1) and collision cell (hexapole) coupled with a time of flight mass analyzer (TOF) that is 
geometrically aligned in the orthogonal configuration with respect to quadrupole mass filter and 
the collision cell as depicted in figure 7.  
QTOF-MS provides both one stage MS and (tandem) MS/MS spectra. During MS mode 
quadrupole Q1 as well as hexapole are operated in radio frequency (RF) only mode. This 
means that the direct current component (DC) of the applied voltages is removed. Thus, all 
ions are focused around the central axis and allowed to be transmitted to the TOF.  
The separation methodology used in TOF is relatively straightforward and simple. The ions are 
subjected to an accelerated voltage and obtain ideally the same kinetic energy before they 
draft or fly down an evacuated tube of a set length. The speed at which the ions fly down the 
tube correlates with their mass and charge. Provided that all ions start their flight at the same 
time, the lighter ions will arrive earlier at the detector than the heavier ones. However, due to 
the distribution of the acquired kinetic energies in the accelerating voltage, not all ions of the 
same m/z values reach the detector simultaneously. Therefore, linear TOF instrumentation 
may influence the resolving power of the analyzer especially for ions of high masses. This 
drawback is solved to a large extent through the use of a reflectron device mounted at the top 
of the TOF tower as displayed in figure 7. The reflectron acts as an ion mirror that compensates 
for the kinetic energy differences between the isobaric ions. Therefore, ions with higher kinetic 
energy will penetrate deeper into the ion mirror. Moreover, the reflectron doubles the flight path 
and improves the resolving power by increasing the time interval between the ions of different 
m/z. TOF analyzer is favorable over quadrupole in qualitative analysis as it may provide higher 
resolution and accurate mass measurements.  
The QTOF-MS can also be used in MS/MS mode which is based on the separation of the ions 
with certain m/z values (precursor ions) by the quadrupole mass filter (Q1) followed by 
collision-induced dissociation (CID) in the collision cell. Here, the precursor ions undergo 
collision with a stream of inert gas (e.g., nitrogen) of a specific energy level in order to produce 
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Figure 7 Schematic design of Q-TOF mass analyzer (courtesy of Agilent Technologies) 
 
Different ionization techniques have been used depending on the chromatographic 
hyphenation. Electrospray ionization (ESI) was applied in combination with LC, whereas 
electron ionization (EI) was realized after gas chromatographic separation. EI is usually 
performed at 70 eV since this energy gives the highest ion yield (figure 8). In contrast to EI, it 
is common in ESI to vary the capillary voltage (typically 2 to 6 kV). 
In addition to the conventional EI at 70 eV for classical fragment libraries, lower energies (LE) 
were also applied using an Agilent 7250 GC-QTOF-MS. This instrument is capable of LE-EI 
(12-20  eV) measurements, due to its optimized source configurations, lenses, magnets and 
tuning. In a recent study, Polet et al. [70] reported that an ionization energy of 15-18 eV was 













Figure 8 Diagram showing the ionization efficiency (ion yield) in EI as a function of energy, adapted from 











Ketoprofen, 2-(3-benzoylphenyl) propanoic acid, is a non-steroidal anti-inflammatory drug 
(NSAID) widely used in the management and treatment of inflammatory diseases, pain relief, 
and chronic arthritis and well known to act as a photosensitizer which has been proved in vitro 
as well as in vivo [72, 73]. Photoirradiation of ketoprofen was used as model reaction in this 
project for photostability studying. Ketoprofen is a benzophenone derivative, which is part of 
some other nonsteroidal anti-inflammatory drugs (NSAIDs) as well as the antiarrhythmic drug 
amiodarone and lipid lowering agents such as fenofibrate. All of these drugs cause 
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2.2.3 Confidence levels for mass spectrometric identifications  
 
Confidence levels for mass spectrometric identifications are required in order to overcome the 
lack of reference standards and to clarify the variations in confidence derived from different 
studies. According to the Metabolomics Standards Initiative (MSI), four levels of metabolite 
identifications can be found in published metabolomics literature [75], which include: 
1. identified compounds; 2. putatively annotated compounds (e.g. without chemical reference 
standards, based upon spectral similarity with public/commercial spectral libraries and/or 
physiochemical properties); 3. putatively characterized compound classes (e.g. based upon 
spectral similarity with known compounds of a chemical class); 4. unknown compounds, 
although unidentified or unclassified these metabolites can be differentiated and quantified 
based upon spectral data. Jeon et al. suggested a framework to clarify these confidence levels 
for specific investigations on biotransformation pathways of biocides and pharmaceuticals in 
freshwater crustaceans [76]. As many cases were found to fit “in between” these proposed 
levels, additional levels were adapted by Schymanski et al. [68]. These levels are illustrated in 
figure 9 and can be described as follows: 
• Confirmed structure (level 1) where measurement of a reference standard has been 
used to confirm the proposed structure by MS, MS/MS and retention time matching 
(RT). If possible, an orthogonal method should also be realized. 
• Probable structure (Level 2) where an exact structure was proposed using different 
evidence and can be further subdivided into library (level 2a) and diagnostic (level 2b). 
Level 2a involves matching literature or library spectrum data where the spectrum-
structure match is unambiguous. Level 2b represents the case where no other structure 
fits experimental data. Therefore, diagnostic MS/MS fragments and/or ionization 
behaviors, parent compound information and the experimental context can 
compensate for the absence of reference standard or literature information. This break 
down into (a) and (b) is useful for research purposes, whereas for practical reporting 
probable structure (level 2) may often be sufficient to indicate the confidence in the 
candidate. 
• Tentative or putative candidate(s) (Level 3) represent(s) the case where evidence 
exists for possible structure(s), but there is insufficient information for one exact 
structure only. For example, the cases where the position of certain substituents could 
not be clarified. 
• Unequivocal molecular formula (Level 4) which indicates that a formula can 
unambiguously assigned using the spectral information. However, insufficient evidence 
exists to propose possible structure.  
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• Exact mass (level 5) where the exact mass (m/z) can be measured in a sample, but 
neither a structure nor a formula can be assigned due to lack of information. Level 5 
can be beneficial for specific investigations where screening or nontarget methods 
allow  tracing of certain masses. However, level 5 should be limited to a few masses of 
specific interest. 
As can be deduced from this classification, structure identification is feasible with levels 1 and 





Figure 9 Classification of confidence levels based on Schymanski et al. [68]
Level 1: confirmed structure
by reference standard
MS, MS2, RT comparison with
Reference Standard. 
Confidence levels of Identification Minimum data requirement
Level 2: Probable structure
a) by library spectrum match
b) by diagnostic evidence
MS, MS2, Library MS2
MS, MS2, Experimental Data
Level 3:Tentative candidate(s)
structure, substituent, class
MS, MS2, Experimental Data
MS isotope/adductLevel 4: Unequivocal molecular formula
Level 5: Exact mass of interest MS
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3 Project highlights 
A comprehensive strategy for both photostability testing and structural characterization of 
photoproducts as well as other drug impurities was established utilizing ketoprofen as a model 
compound. Photoproducts were generated by a tailored online reactor HPLC hyphenation and 
identified by mass spectrometry (manuscript 1). Subsequent fragmentation elucidation of these 
photoproducts and related compounds was achieved using isotopic labelling and recent mass 
spectrometric instrumentation (manuscript 2). 
The online reactor HPLC hyphenation is equipped with an exchangeable pen light source and 
online-solid phase extraction (SPE). This instrumental design includes an integrated flush 
pump used to load the drug substance into the photoreactor where irradiation takes place.  
A schematic display of the flow configuration is shown in figure 10. Following irradiation, the 
remaining drug substance and its photoproducts are trapped on SPE cartridge. Subsequently 
the quaternary pump is used to backflush the analytes out of the cartridge onto the analytical 
column.  
Separation of the analytes can be accomplished on superficially porous particle (SPP) 
columns. The use of such columns offers several advantages over the conventional fully 
porous columns especially during the method development phase. As the solid core does not 
participate in the diffusion (which only occurs on the porous outer shell), the efficiency of the 
separation is increased compared to the porous columns of the same size. This is not achieved 
at the expense of the resulted backpressure, which remains at relatively low limits. As a 
consequence, the flow rate can be increased or another system setup may then be realized  
using the photoreactor directly in front of the separation column.  
As can be deduced from the schematic display (Figure 10), the analytes with their 
accompanied photoproducts can be identified using different detectors such as DAD or mass 
spectrometry. Possible offline/online hyphenation with different mass spectrometric techniques 
can offer both optimum detection as well as structural characterization of the resulting 
substances. Peak-based fractionation and scale up processes may also be realized in order 
to generate reference material for further structural confirmation with NMR or toxicity studies. 
Using this experimental design, kinetic studies of ketoprofen were easily performed with 
qualitative and quantitative perspectives combined into one experimental system and several 
photoproducts were additionally detected. Both methylation and trimethylsilylation after peak 
based fractionation were used for EI-MS characterization of the analytes. 





Figure 10 Schematic display of flow configuration of the online photostability experiments: PR: photoreactor; W: 
waste; P1: FlexCube pump; P2: quaternary pump; SPE: solid phase extraction; D: detector.(Irradiation and trapping: 
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Substantiation was achieved by high resolution accurate mass spectrometry (QTOF-MS). 
Further mass spectrometric investigation was obtained by isotopic labelling, as deuterated 
photoproducts were derived via photolysis experiments. 
1-(3-benzoylphenyl) ethenone (BP05, keto 2), 3-(1-hydroxyethyl) benzophenone (BP06, 
keto 1) and ethylbenzophenone (BP08, keto 3) were assigned as photproducts with the highest 
level of confidence (level 1) according to Schymanski et al [68]. This assignment allowed for 
generation of site specific isotopes of the respective compounds. In addition to structure 
confirmation, the resulted photoproducts can be used as internal standard for future analysis 
or for toxicological tests. Two other photoproducts were tentatively assigned to 
hydroxyethylphenyl-hydroxyphenyl-methanol (keto 4) and vinyl-benzophenone (keto 5) based 
on their mass spectral data . The both are classified as level 3 according to Schymanski et al. 
Fragment explanation of ketoprofen and its derived photoproducts were deduced from ESI-
MS(/MS) experiments. Fragments of ketoprofen attributed to the loss of formic acid and 
benzene were successfully identified with high accuracy and confirmed by analysis of 
deuterated ketoprofen (ketoprofen-d3). Cleavage of phenyl moiety was characterized as 
common loss for (BP05, keto 2), (BP06, keto 1) and (BP08, keto 3) in their product ion spectra 
and substantiated from the corresponding product ions of ketoprofen-d3 derived isotopologues.  
Through this study, the online photoreactor-SPE-HPLC system and the concomitant mass 
spectrometric identification showed their potential for fast and easy photostability testing. Data 
achieved in the traditional photochamber system and the online photoreactor HPLC 
hyphenation system are qualitatively similar. The online reactor HPLC hyphenation may also 
be used for the simulation of photoreactions in vivo as irradiation of mixtures may be also 
realized in the photoreactor to mimic the biological situation. Therefore, this system may be 
beneficial to reduce time consuming in vitro experiments and animal trials.  
All of the assigned photoproducts were found to be benzophenone derivatives. Due to their 
common use and spread in the environment from several sources [77, 78], benzophenone 
derivatives are considered in many chromatographic and mass spectrometric investigations, 
where structural elucidation is required. However, proper structure confirmation may be 
challenged by various factors including, scantiness of the compounds and lack of reference 
standards. An established flow scheme proposed in this project showed its ability to track 
ketoprofen as a model compound together with seven of its related benzophenone impurities 
including those listed in the European Pharmacopeia (Ph. Eur. 9.0) and identify their chemical 
background. The established workflow incorporates isotopic labelling in addition to various 
mass spectrometric techniques. Two different deuteration procedures were successfully 
established in order to obtain site specific dx-derivatives. These included generation of 
deuterated photoproducts using BP01-d3 as starting material via photolysis experiments and/or 
introduction of d9-TMS groups into the compounds where applicable. 18O-Labelling was used 
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to further substantiate fragment structure proposals. Tiered mass spectrometric approach was 
implemented with different ionization energies, low resolution as well as high resolution 
accurate mass analyses. This helped to substantiate rationales for structure assignments. 
Moreover, MS/MS measurements were well integrated in the flow scheme to further elucidate 
fragmentation pathways. 
Surprizing findings concerning mass spectral fragments of the analytes undermined common 
textbook knowledge on fragmentation reactions in EI-MS. This is ably illustrated, for instance 
by [M-31]+ fragment ion (CF2) in the studied group, which included arylpropionic acid 
derivatives of ketoprofen (BP01), (3-benzoylphenyl) acetic acid (BP02), (2RS)-2-[3-(4-
methylbenzoyl)phenyl] propanoic acid (BP03) and (2RS)-2-(3-benzoylphenyl) propanamide 
(BP04). In this case CF2 cannot be assigned to a loss of [OCH3]● from the molecular ion, but 
as consecutive losses of methyl radical and methane ([M-C2H7]+). Figure 11 illustrates an 
example of the progressive application of the flow scheme for fragment ion interpretation of 
([M-31]+) of BP-01-TMS (ketoprofen). In line with these findings, (1-(3-benzoylphenyl) 
ethenone) derivative (BP05-TMS) and 3-(1-hydroxyethyl)benzophenone) derivative (BP06-
TMS) also show fragment ion [M-31]+.  
Another example of the importance of the isotopic labelling study and the tiered mass 
spectrometric approach is obviously shown in the mass spectrum of non-silylated 
benzophenone derivative of 3-ethylbenzophenone (BP08) exemplified by fragment ion m/z 105 
(figure 12). As site specific labelling could not be achieved by TMS derivatives of non-silylated 
compounds, the online photoreactor HPLC hyphenation was used to generate the 
isotopologues for further confirmation.  
Based on these findings, the comprehensive strategy of the online photostability testing and 
mass spectrometric characterization offers an effective perspective to track drug related 
compounds and elucidate their structures. 
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   BP01-TMS (M+•)                                                [M-CH3]+                                            [M-C2H7]+ 
Figure 11: Example showing the application of flow scheme including isotopic labelling study and the tiered mass 
spectrometric approach for fragment ion interpretation of ([M-31]+) of BP-01-TMS (ketoprofen). Same strategy 
(manuscript 2 ) was applied for all studied benzophenone TMS -derivatives (BP01-TMS to BP06-TMS). 
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Figure 12: Example showing the application of flow scheme including the isotopic labelling study and the tiered 
mass spectrometric approach for fragment ion interpretation of [M-105]+ of BP08  (3-ethylbenzophenone)
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4 Publications  
4.1 Manuscript NO. 1 
“Photostability testing using online reactor HPLC hyphenation and mass spectrometric 
compound identification illustrated by ketoprofen as model compound” 
Jaber Assaf, Diego Zulkiewicz Gomes, Bernhard Wuest, Maria Kristina Parr 
 
Journal of Pharmaceutical and Biomedical Analysis 145 (2017) 414–422 
https://doi.org/10.1016/j.jpba.2017.07.006 
 
Investigations on the photochemical stability of pharmaceutical substances are mandatory in 
drug devel-opment and licensing as photo-induced degradation of an active pharmaceutical 
ingredient (API) may not only lead to decreased API concentrations but also to toxic or reactive 
products. Thus, the US Food and Drug Administration (FDA) and the International Council for 
Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) issued 
Guidance for Industry Q1B “Photostability Testing of New Drug Substances and Products” for 
testing of pure but also packed drugs. However, photoproducts are also known to be generated 
in vivo under sunlight exposure of the skin and lead to considerable amounts of adverse drug 
effects. Herein we present an alternative system that may be used for photostability testing 
mimicking both sit-uations. It combines a tailored photoreactor with an exchangeable pen light 
source and a modified HPLC system with online-SPE. Identification of photoproducts may be 
performed using mass spectrometry. The potential of accurate mass spectrometry as a tool 
for identification of photoproducts was demonstrated as well. A comparison of the online 
photoreactor system and the traditional photochamber irradiation was performed using 
ketoprofen for proof of concept. In both designs acetylbenzophenone and ethylben-zophenone 
were detected as main photoproducts. The new device allows for fast and easy photostability 
studies that may help to reduce time consuming in vitro experiments and animal trials. Using 
state of the art instruments kinetic studies could also easily be performed with qualitative and 
quantitative per-spectives combined into one experimental design with only very low amounts 
of API needed. This may be useful in early drug development, where only small amounts of 
API are available. Scale-up may also be easily realized for the generation of reference material 
for quantification and quality control (QC) processes as well as for toxicity testing. 





4.2 Manuscript NO. 2 
 
Reconsidering mass spectrometric fragmentation in EI-MS- New insights from recent 
instrumentation and isotopic labelling exemplified by ketoprofen and related compounds 
 
 





Rationale: In various fields of chemical analyses, structurally unknown analytes are 
considered. Proper structure confirmation may be challenged by the low amounts of analytes 
that are available e.g. in early stage drug development, in metabolism studies, in toxicology or 
in environmental analyses. In these cases, mass spectrometric techniques are often used to 
build up structure proposals for these unknowns. Fragmentation reactions in mass 
spectrometry are known to follow definite pathways that may help to assign structure elements 
by fragment ion recognition. This work illustrates an investigation of fragmentation reactions 
for gas chromatography electron ionization mass spectrometric characterization of 
benzophenone derivatives using the analgesic drug ketoprofen and seven of its related 
compounds as model compunds.  
Methods:  Deuteration and 18O-labelling experiments along with high-resolution accurate mass 
and tandem mass spectrometry were used to further elucidate fragmentation pathways and to 
substantiate rationales for structure assignments. Low energy ionization was investigated to 
increase confidence in the identity of the molecular ion. 
Results: The high-resolution mass analyses yielded unexpected differences that led to 
reconsideration of the proposals. Site-specific isotopic labelling helped to directly trace back 
fragment ions to their respective structure elements. The proposed fragmentation pathways 
were substantiated by MS/MS experiments. 
Conclusion: The described method may offer a perspective to increase the level of confidence 
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5 Summary and Outlook  
Here a comprehensive strategy for both photostability testing of drug substances and a 
complementary structural characterisation approach for drug related compounds, including 
photoproducts was established and tested.  
The photostability studies were performed using a tailored online photoreactor-SPE-LC system 
and its potential was demonstrated by irradiation of Ketoprofen as a model compound. The 
new devise allows fast and easy photostability testing that may help to reduce time and animal 
trials. Using this state of the art setup, kinetic studies can easily be performed with qualitative 
and quantitative perspectives combined into one experimental design with only very low 
amounts of pharmaceutical substance needed. The system allows online coupling using ESI-
MS or offline EI-mass spectrometric characterization of photoproducts after fractionation. 
Moreover, scale-up process can be realized for structure confirmation and can be used for 
further toxicity tests and as reference material for product quantification. Deuterated 
photoproducts were derived via photolysis experiments and used for further inspections on 
structural proposals. 
In order to increase the confidence level of MS-characterization of unknown compounds, a 
tiered mass spectrometric approach was suggested through this work for EI-mass 
spectrometric characterization of ketoprofen and its related benzophenone derivatives 
including those identified as photoproducts. In addition to high resolution accurate mass 
measurements derived from recent mass spectrometric instrumentation, the established 
approach comprises isotopic labelling together with tandem mass spectrometry. 
The isotopic labelling was performed by both deuteration and 18O labelling using different 
methods in order to produce compounds that contain deuterium or oxygen-18O at definite 
positions. The suggested approach demonstrated its potential as a powerful tool for mass 
spectrometric characterization of benzophenone derivatives and fragment ion recognition. 
Upon these promising results, it can be used to increase the level of confidence in the 
identification of unknown analytes, where reference material is not (yet) available. 
The new photostability setup testing together with the established mass spectrometric 
approach can be beneficial for the simulation of photoreactions in vivo. This could be achieved 
by irradiation of mixtures to mimic the biological situation and identify the resulted compounds.. 
A similar strategy may also be used for other stability testing utilizing a slightly different reactor 
design, in which various factors affecting drug substances such as temperature and 
environmental conditions can be investigated. Structure elucidation as well as generation of 
reference materials upon these stability testing can then be realized. 
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5. Zusammenfassung und Ausblick 
eine umfassende Strategie wurde hier für die Prüfung der Photostabilität von Arzneistoffen und 
ein komplementärer Ansatz zur strukturellen Charakterisierung von Arzneimittelwirkstoffen 
einschließlich Photoprodukten etabliert und getestet. 
Die Photostabilitätsstudien wurden unter Verwendung eines entwickelten Online-
Photoreaktor-SPE-LC-Systems durchgeführt, und sein Potential wurde durch Bestrahlung von 
Ketoprofen als Modellverbindung gezeigt. Das neue Gerät ermöglicht schnelle und einfache 
Photostabilitätstests, die Zeit und Tierversuche reduzieren können. Unter Verwendung dieses 
Stands der Technik System konnten kinetische Studien leicht mit qualitativen und quantitativen 
Perspektiven durchgeführt werden, die in einem experimentellen Design mit nur sehr geringen 
benötigten Mengen an pharmazeutischer Substanz kombiniert wurden 
Das System ermöglicht die Online-Kopplung mit ESI-MS oder die Offline-EI-
Massenspektrometrie-Charakterisierung von Photoprodukten nach der Fraktionierung. 
Darüber hinaus kann der Scale-up-Prozess zur Strukturbestätigung realisiert und für weitere 
Toxizitätstests sowie als Referenzmaterial zur Produktquantifizierung genutzt werden. 
Deuterierte Photoprodukte wurden mittels Photolyseexperimenten gewonnen und für weitere 
Untersuchungen zu Strukturvorschlägen verwendet. Um das Konfidenzniveau der MS-
Charakterisierung unbekannter Verbindungen zu erhöhen, wurde in dieser Arbeit ein gestufter 
massenspektrometrischer Ansatz für die EI-massenspektrometrische Charakterisierung von 
Ketoprofen und seinen verwandten Benzophenonderivaten, einschließlich solcher, die als 
Photoprodukte identifiziert wurden, vorgeschlagen. Zusätzlich zu hochauflösenden akkurate 
Massenmessungen, die aus neueren massenspektrometrischen Instrumenten realisiert 
wurden, umfasst der etablierte Ansatz die Isotopenmarkierung zusammen mit der Tandem-
Massenspektrometrie.  
Die Isotopenmarkierung wurde sowohl mit Deuterierung als auch mit 18O-Markierung unter 
Verwendung verschiedener Methoden durchgeführt, um Verbindungen herzustellen, die 
Deuterium oder Sauerstoff-18O an bestimmten Positionen enthalten. Der vorgeschlagene 
Ansatz zeigte sein Potenzial als ein leistungsfähiges Werkzeug für die 
massenspektrometrische Charakterisierung von Benzophenonderivaten und die Fragment-
Ionen identifizierung. Nach diesen vielversprechenden Ergebnissen kann der Ansatz 
verwendet werden, um das Vertrauen in die Identifizierung von unbekannten Analyten zu 
erhöhen, wo Referenzmaterial (noch) nicht verfügbar ist.  
Das neue Photostabilitätstestverfahren zusammen mit dem etablierten 
massenspektrometrischen Ansatz kann für die Simulation von Photoreaktionen in vivo von 
Vorteil sein. Dies könnte durch Bestrahlung von Gemischen erreicht werden, um die 
biologische Situation nachzuahmen und die resultierenden Verbindungen zu identifizieren. 
Eine ähnliche Strategie kann auch für andere Stabilitätstests verwendet werden, die ein etwas 
Summary and Outlook 83 
 
anderes Reaktordesign verwenden, bei dem verschiedene Faktoren untersucht werden 
können, die Arzneimittelsubstanzen wie Temperatur und Umweltbedingungen beeinflussen. 
Die Strukturaufklärung sowie die Erzeugung von Referenzmaterialien bei diesen 
Stabilitätstests kann dann realisiert werden. 
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